The use of a commercial suspending agent increased both the area under curve and maximum concentration of voriconazole compared to mixing the drug with water. Polyuria was more severe in the treatment groups than in the control group. Study weaknesses: This study used a small sample size of healthy animals and a small control group and was non-randomised. Pharmacokinetics of voriconazole are dose-dependent; therefore, it is not possible to accurately extrapolate plasma concentrations of different doses. There may be an induction of metabolism effect of voriconazole administration in African grey parrots, where recurrent administration stimulates the hepatic enzymes that metabolise the drug. The single dose group received subsequent single doses 14 days or 21 days after the first dose, which may have affected drug clearance. The investigators were not blinded to the treatment but acknowledge this in the paper. The single dose trial plasma measurements at 24 hours following administration were all excluded because of inconsistencies in the data.
Paper 2: Evaluation of the influence of formulation, food intake and species on kg or 18 mg/kg voriconazole orally, either mixed with water or with a commercial suspending agent. Single doses were repeated with the same individuals 14 or 21 days after each previous dose. Group 2 (n=6) received multiple doses of 18 mg/kg voriconazole (given orally every 12 hours) mixed with a commercial suspending agent for nine days. A control group (n=2) received tap water (equivalent volume, given orally every 12 hours for nine days). Study type: Non-randomised, controlled trial Outcomes: Plasma samples were collected at 30 minutes, one, six, 12 and 24 hours after drug administration for the single dose trials. Pooling of data points produced a mean plasma concentration of voriconazole which was used for pharmacokinetic analysis. For the multidose trial, plasma samples were collected twice for measurement of the trough plasma concentration (ie, lowest concentration of voriconazole reached before the next dose being administered). Key results: Increases in the dose of voriconazole resulted in disproportional increases in maximum concentration of the drug in plasma. Plasma half-life of voriconazole was short (1.1 to 1.6 hours). 
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Search parameters
The search terms Aspergillus OR aspergillosis OR mycoses OR mycosis AND 'African grey parrot' OR 'African gray parrot' OR 'African grey parrots' OR 'African gray parrots' OR 'Timneh grey parrot' OR 'Psittacus erithacus' OR 'Psittacus erithacus timneh' OR 'Psittacus timneh' AND Voriconazole were used.
Search outcome
• Two relevant papers found in CAB Abstracts • One relevant paper found in Medline • Two relevant papers from both Medline and CAB.
Search last performed: December 7, 2017
Summary of evidence 
Bottom line
Ten to 18 mg/kg twice daily is a reasonable dose of voriconazole to administer to African grey parrots infected with aspergillosis. Using a commercial suspending agent, rather than just mixing in water, may greatly increase the bioavailability of the drug. More research is needed to determine the optimum duration of treatment. The drug can be given with or without food. 
Authors of this Critically Appraised Topic
Comments
A minimum inhibitory concentration (MIC) of 0.38 μg/ml voriconazole has been reported for Aspergillus infections cultured from falcons. 3 Both low dose (6 mg/kg) and high dose (10 to 18 mg/ kg) treatments in these studies achieved maximal concentrations exceeding 0.38 μg/ml. Trough plasma concentrations were maintained above MIC for approximately 10 hours in the single dose 10 mg/kg and 12 mg/kg trials and 12 hours for the single dose 18 mg/kg trial. Due to a possible induction of the metabolism effect, the multiple dose 18 mg/kg trough plasma concentration was lower than the single dose. Both of these studies were carried out on healthy birds over a short time frame. It is possible that the pharmacokinetics of voriconazole will be different in parrots with aspergillosis, as well as with extended treatments. One of the studies was carried out on Timneh African grey parrots and the other on Congo African grey parrots. The Timneh African grey parrot was previously considered a conspecific to the Congo African grey parrot but is now considered a separate species (Psittacus timneh). Further work is needed to more accurately identify the doses of voriconazole needed voriconazole plasma concentration in birds Critically Appraised Topics (CATs) are a standardised, succinct summary of research evidence organised around a clinical question, and a form of evidence synthesis used in the practice of evidence-based medicine (EBM) and evidence-based veterinary medicine (EBVM). Access to CATs enables clinicians to incorporate evidence from the scientific literature into clinical practice and they have been used to teach EBVM at the University of Bristol's School of Veterinary Sciences since 2011. CATs from the University of Bristol will be regularly published in the Clinical Decision Making section of Vet Record. The first CAT was published in VR, 30 January, 2016, vol 178, pp 118-119. 
